Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Gary Miller remembers being told by a [former] doctor that his fatty liver disease was a “benign condition.”“This doctor ...

Indian contract drug manufacturer OneSource Specialty Pharma expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top executive said ...

A large European study found that consuming a greater variety of plant-based proteins, vegetables, and major food groups is linked to a lower risk of developing type 2 diabetes. The protective effect ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

A popular fat found in olive oil may not be as innocent as it seems. Scientists discovered that oleic acid, a major component of many high-fat foods, uniquely spurs the growth of new fat cells by ...

Novo Nordisk will pay U.S. biotech Deep Apple Therapeutics up to $812 million in a partnership deal aimed at developing drugs to treat cardiometabolic diseases, including obesity.